Amphastar Pharmaceuticals, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1.1% | -10.8% | +15.0% | -11.2% | +4.3% | -3.3% | +21.7% | +6.3% | +18.7% | -11.0% | -0.9% | +1.4% | +4.1% | +1.6% | +1.3% | -2.8% | +15.0% | +7.4% | -1.3% | +10.4% | +7.7% | -0.4% | +2.6% | -2.7% | +12.4% | +3.7% | +4.1% | +23.9% | -1.4% | -3.5% | +6.1% | +3.5% | -1.2% | -8.6% | +2.3% | +10.0% | -4.6% | -6.5% | +7.4% | – | |
| – | +19.0% | -22.3% | +13.6% | -3.0% | +6.8% | +3.8% | +8.6% | +3.1% | +18.8% | -11.1% | -4.6% | -3.8% | +11.4% | -4.3% | +10.0% | -10.8% | +25.9% | -1.7% | -6.5% | +12.4% | +6.0% | -0.2% | -6.9% | +2.5% | +3.6% | +3.6% | +10.3% | -1.1% | +13.6% | +3.1% | +3.2% | -0.4% | +15.0% | -14.6% | +3.1% | +6.0% | +4.6% | +3.5% | -10.3% | – | |
| – | -27.7% | +14.4% | +17.2% | -22.8% | -0.3% | -17.1% | +53.3% | +11.9% | +18.6% | -10.9% | +4.8% | +8.8% | -5.3% | +10.3% | -9.9% | +10.0% | +0.9% | +22.0% | +5.4% | +8.0% | +9.9% | -0.7% | +13.5% | -7.6% | +21.6% | +3.8% | -1.5% | +49.0% | -11.3% | -9.2% | +9.0% | +7.1% | -15.0% | -1.6% | +1.5% | +14.1% | -13.2% | -17.9% | +32.9% | – | |
| – | +26.3% | -8.4% | -4.6% | -6.4% | +13.5% | +25.2% | +8.5% | -26.7% | +47.6% | -12.7% | +9.5% | +16.3% | +5.6% | -22.1% | +5.5% | +9.3% | +2.8% | -18.6% | +22.7% | -40.6% | +60.7% | -6.1% | +40.5% | -18.8% | -6.9% | +15.0% | -15.0% | -1.1% | +22.5% | -30.3% | +24.0% | +19.4% | -13.9% | +10.8% | -0.1% | +11.3% | +4.3% | +14.7% | -17.1% | – | |
| – | -0.9% | +5.9% | +7.9% | -4.7% | -21.0% | +19.3% | +6.1% | +14.9% | +3.0% | +18.2% | -23.9% | -11.3% | -4.7% | +2.3% | +48.2% | -26.7% | +3.1% | +27.5% | -5.0% | -25.1% | -2.6% | +17.4% | -20.0% | +20.1% | -11.3% | +26.9% | -8.9% | +3.0% | +3.7% | +19.5% | -15.3% | +11.6% | -12.7% | +23.6% | -12.5% | +182.1% | -58.3% | +9.5% | +1.2% | – | |
| – | +12.2% | -1.7% | +2.1% | -4.5% | -5.2% | +21.3% | +7.5% | -7.9% | +24.1% | +2.8% | -7.8% | +4.6% | +2.4% | -12.7% | +23.0% | -8.6% | +2.9% | +2.0% | +6.3% | -28.3% | +21.1% | +7.0% | +12.6% | -8.4% | -5.5% | +21.2% | -11.3% | -0.3% | +18.0% | -6.8% | +1.7% | +12.4% | -7.5% | +15.6% | -7.6% | +65.5% | -31.7% | +13.2% | -5.2% | – | |
| – | -177.8% | – | +55.6% | -229.1% | – | – | – | – | -39.4% | -305.3% | – | +147.1% | -110.1% | – | -139.1% | – | -18.1% | +258.0% | +2.5% | +134.6% | -2.1% | -10.9% | +14.8% | -6.4% | +62.9% | -11.6% | +10.4% | +97.0% | -25.7% | -11.1% | +15.0% | +3.3% | -20.9% | -17.4% | +13.1% | -40.0% | +40.6% | -61.7% | +191.5% | – | |
| – | -80.8% | +253.7% | +24.1% | +11.4% | -49.2% | -86.6% | +455.6% | +24.0% | -99.2% | +2,900.0% | -20.0% | -8.3% | +95.5% | +76.7% | -53.9% | +400.0% | -49.7% | +18.2% | -17.3% | +512.8% | -68.1% | +111.3% | +11.8% | +42.6% | -6.7% | -24.6% | +805.0% | +280.4% | -31.0% | -8.9% | 0.0% | -22.2% | -4.1% | -2.2% | -0.1% | +0.0% | +5.5% | -1.2% | +1.6% | – | |
| – | -177.0% | – | +111.0% | -162.7% | – | – | – | – | -77.1% | -716.8% | – | -97.4% | -25.0% | +389.5% | -125.9% | – | -195.3% | – | +178.0% | +164.8% | -28.4% | +5.1% | -19.2% | -2.0% | +83.7% | -20.4% | -0.8% | +94.6% | -35.4% | +15.8% | +6.2% | -5.1% | -7.8% | -29.8% | +27.5% | -45.3% | +48.3% | -68.5% | +283.4% | – | |
| – | -189.1% | – | +96.6% | -280.3% | – | – | – | – | -217.8% | – | – | -95.8% | -27.9% | +429.0% | -103.3% | – | -141.6% | – | +384.4% | +19.5% | +7.6% | -43.3% | +36.2% | +18.2% | +11.1% | -7.4% | -5.5% | +119.7% | -66.7% | -11.7% | +198.0% | -41.0% | -17.3% | -7.0% | +48.9% | -49.9% | +79.8% | -51.5% | +125.7% | – | |
| – | -170.5% | – | +120.8% | -91.1% | +738.9% | -593.6% | – | – | -21.9% | -53.5% | +5,405.4% | -97.3% | -178.3% | – | -104.9% | – | -260.1% | – | +54.1% | +280.4% | -33.1% | +22.7% | -28.5% | -8.5% | +113.6% | -23.2% | +0.4% | +88.4% | -26.5% | +19.4% | -12.1% | +6.5% | -6.1% | -33.4% | +22.7% | -44.1% | +40.8% | -73.7% | +372.7% | – | |
| – | -107.4% | – | +180.8% | -70.7% | +40.7% | -269.9% | – | +8,984.0% | -13.0% | -84.6% | +630.3% | +14.8% | -10.6% | +70.6% | -62.0% | +212.9% | -99.2% | +10,281.9% | +75.8% | +111.1% | -24.2% | +6.8% | -16.0% | +0.4% | +61.5% | -16.0% | +5.0% | +109.3% | -29.0% | +8.2% | +4.5% | -5.7% | -5.5% | -19.5% | +18.1% | -32.2% | +30.1% | -39.3% | +36.6% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.